CANCER OF THE PANCREAS
Clinical trials for CANCER OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE PANCREAS trials appear
Sign up with your email to follow new studies for CANCER OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on pancreatic cancer in early trial
Disease control TerminatedThis early-phase study tested a treatment called huCART-meso cells, which are a patient's own immune cells modified to recognize and attack pancreatic cancer cells. The trial included 54 people with advanced pancreatic cancer that could not be removed by surgery. The main goal wa…
Matched conditions: CANCER OF THE PANCREAS
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New cancer drug trial halted early – what we know
Disease control TerminatedThis early-stage trial tested an experimental drug called NUV-868, alone or with other cancer drugs, in 82 adults with advanced solid tumors (including ovarian, pancreatic, prostate, and breast cancers). The goal was to find safe doses and check for early signs of effectiveness. …
Matched conditions: CANCER OF THE PANCREAS
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC